Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached an initial rampdown phase for bug fixes, with the feature set now frozen. The following 10 features are ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

GIFs are the most fun and popular way you can interact on Twitter. For the uninitiated, GIFs are short animated video clips that you can use for visual interaction. Twitter boasts a dedicated GIF ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Community driven content discussing all aspects of software development from DevOps to design patterns. As developers navigate their way around the technical landscape, they inevitably run into terms ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

The Internet Archive made it easier to search for '90s-era GIFs. GifCities contains millions of animations from the decade of flannel shirts and Soup Nazis. The GIFs were pulled from old GeoCities ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...